The global bulk-drug compounding market is set to experience significant growth over the next decade, driven by increasing demand for customized medications amid persistent drug shortages. Estimated to be worth USD 11,887.6 million in 2024, the market is projected to surge to USD 19,735.7 million by 2034, growing at a steady compound annual growth rate …